PUNE, India, Feb. 24, 2021 /PRNewswire/ — Global demand for Single-Use Bioreactor Market Size, in terms of revenue, was worth of USD 1.10 Billion in 2017 and is expected to reach USD 4.50 Billion in 2027, growing at a CAGR of 15.13% from 2021 to 2027. The global Single-Use Bioreactor is expected to grow at a significant rate due to the number of driving factors.
Single-Use Bioreactor Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.
Single-Use Bioreactor top Manufacturers:
Sartorius, Xcellerex, Eppendorf, Applikon, Danaher Corporation, Merck Millipore, Thermo Scientific HyClone, PBS Biotech and others.
Get Sample Copy of this [email protected] https://brandessenceresearch.com/requestSample/PostId/1463
A bioreactor is generally used for growing organisms like animal cell, bacteria, yeast and others in controlled atmosphere and helps in the production of vaccines, antibodies, pharmaceuticals and others. The disposable bioreactor has a disposable bag instead of culture vessel which is known as Single-Use Bioreactor. This disposable bag has three layers of plastic foil made from Polyethylene terephthalate or LPDE, PVA or PVC and contact layer from PVA or PP. The single use bioreactors are better in performance and scalable compared to stainless steel bioreactors. The traditional bioreactors have a validation issues due to its complexity and cleaning process which is avoided by new single-use bioreactors. This system also holds other advantages like less turn around time, lowers risk of contamination, cost-effectiveness, and easy to install & movement.
During this COVID-19 pandemic, some industries severely affected, and some industries have flourished. Healthcare industry and Bioprocessing manufacturing industries are affected positively in terms of revenue and funding. Due to the rise in demand of COVID-19 Vaccines and Medications, various governments and organizations are funding and prioritizing Biomanufacturing companies for key technologies like perfusion reactors, single-use equipments, and chromatography resins. Hence, drug and vaccine manufacturers are significantly opting for disposable components like single-use bioreactors to avoid contamination issues.
Single-Use Bioreactor Market Segmentation Analysis:
Global Single-Use Bioreactor Market report is segmented on the basis of construction, mode, sizes, applications and region & country level. On the basis of construction, it is classified as Stirred Bioreactor and Rocking Bioreactor. Based upon mode, global Single-Use Bioreactor market is classified into Batch, Continuous, and Fed-Batch. Based upon the size, global Single-Use Bioreactor market is classified into 500L, 1000L, 2000L and 6000L. The market is classified on Application as Academic, Pharmaceutical, Environment and Life sciences.
By Construction: Stirred Bioreactor, Rocking Bioreactor
By Mode: Batch, Continuous, Fed-Batch
By Size: 500L, 1000L, 2000L, 6000L
By Application: Academic, Pharmaceutical, Environment, Life sciences
News: Cytiva’s New Manufacturing in Shrewsbury, USA
January 15, 2021; Cytiva opened new manufacturing facility for Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US in December, 2020in collaboration with Biomedical Advanced Research and Development Authority (BARDA). This facility has been developed as a company’s 5 year plan for expanding global manufacturing with total investment $500 million.
Thermo Scientific HyPerforma Bioreactors got Application Specific Enhancements
October 09, 2020; To shift the process specific solutions, Thermo Fisher Scientific introduced the application specific enhancements to HyPerforma Single-Use Bioreactors. It is in creation with the requirements of cell cultures, intensified fed-batch and perfusion. This enables the developers to focus on solutions for diverse bioproduction processes.